PHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement Post author:GHIAA Admin Post published:August 31, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement
PHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement Post author:GHIAA Admin Post published:August 29, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement
PHS – Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement Post author:GHIAA Admin Post published:August 28, 2023 Post category: Continue ReadingPHS – Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement
PHS – Biosyn, HIV Prophylactic Exclusive License Agreement Post author:GHIAA Admin Post published:August 25, 2023 Post category: Continue ReadingPHS – Biosyn, HIV Prophylactic Exclusive License Agreement
NIH – Fluidigm, COVID-19 Diagnostic Development Agreement Post author:GHIAA Admin Post published:August 23, 2023 Post category: Continue ReadingNIH – Fluidigm, COVID-19 Diagnostic Development Agreement
DNDi Template Development Collaboration and License Agreement Post author:GHIAA Admin Post published:April 20, 2023 Post category: Continue ReadingDNDi Template Development Collaboration and License Agreement
DNDi Template Research Collaboration and License Agreement Post author:GHIAA Admin Post published:April 18, 2023 Post category: Continue ReadingDNDi Template Research Collaboration and License Agreement
MPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement Post author:GHIAA Admin Post published:March 7, 2023 Post category: Continue ReadingMPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement
MPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement Post author:GHIAA Admin Post published:March 6, 2023 Post category: Continue ReadingMPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement